Science

Insights into transmission dynamics of Oropouche virus

A study on Oropouche virus (OROV) has shed light on recent and historical outbreaks of this neglected virus in Latin America and the Caribbean. The study was performed in collaboration with Euroimmun and Euroimmun Brazil and was published in Nature Medicine. Background to Oropouche virus OROV is an arbovirus that causes the febrile illness Oropouche […]

Science

Seeing elephants and drinking water from a porcelain vase: the psychiatric face of autoimmune encephalitis

Identifying autoimmune encephalitis (AIE) in patients with psychiatric symptoms is challenging, especially since many associated autoantibodies are rare and not routinely tested. A recent case study of steroid-responsive psychosis linked to anti-septin-7 antibodies — characterised in collaboration with Euroimmun and published in Translational Psychiatry — highlights the need to consider autoimmune causes in primary mental

Andes virus outbreak on cruise ship
Products

When rare zoonoses travel Hantavirus infections from cruise ship to intensive care and diagnostics

In April 2026, the MV Hondius set off from Patagonia. A few weeks later, this cruise raised concerns among health institutions in Europe, North America, Africa, Australia and New Zealand: Some passengers had developed severe hantavirus cardiopulmonary syndrome (HCPS), three of them died.1 The outbreak drew attention to the pathogen, which was previously mainly associated

Science

New study broadens understanding of anti-IgLON5 disease

A case of anti-IgLON5 disease presenting with unusual clinical features has expanded current understanding of this rare autoimmune disorder. The case was investigated in a collaborative study between Euroimmun and clinics in Lübeck and Hamburg (Germany) and published in the Journal of Neurology. What is anti-IgLON5 disease?  Anti-IgLON5 disease is a rare and poorly understood

Company

Euroimmun and IDS: Working together for the IDS i20

#bettertogether Last spring, IDS and Euroimmun launched the new random access instrument IDS i20. This new automation solution followed the random access instruments IDS-i10 and IDS-iSYS already established in the market. The device was developed based on IDS’ 50 years of expertise in laboratory automation – always focusing on maximum convenience for the users and reliability. For

Scroll to Top